[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-KMDA":3,"homepage-market-summary":34,"stock-news-KMDA":176},{"ticker":4,"date":5,"profile":6,"dividend":14,"quote":18},"KMDA","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":9,"founded":9,"is_fund":13,"issuer":9,"category":9},"Kamada Ltd","Nasdaq",null,"Common Stock","Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.","462",false,{"dividend_yield":15,"annual_dividend":16,"frequency":17,"next_ex_date":9},2.125,0.17,"Annual",{"close":19,"open":20,"high":21,"low":22,"prev_close":23,"change":24,"percent_change":25,"volume":26,"transactions":27,"vwap":28,"high_52w":29,"low_52w":30,"avg_volume_52w":31,"range_52w_percent":32,"record_count":33},8,8.11,8.13,7.93,8.31,-0.31,-3.73,137506.343128,2103,8.0186,9.35,6.5,80362.61045858168,52.6,3357,{"status":35,"indices":36,"watchlist":79,"sectors":101,"benchmarks":156},"success",[37,45,52,59,66,72],{"symbol":38,"name":39,"price":40,"change":41,"pct_change":42,"is_up":43,"sparkline":44,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":46,"name":47,"price":48,"change":49,"pct_change":50,"is_up":43,"sparkline":51,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":53,"name":54,"price":55,"change":56,"pct_change":57,"is_up":43,"sparkline":58,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":60,"name":61,"price":62,"change":63,"pct_change":64,"is_up":43,"sparkline":65,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":67,"name":68,"price":69,"change":70,"pct_change":42,"is_up":43,"sparkline":71,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":73,"name":74,"price":75,"change":76,"pct_change":77,"is_up":43,"sparkline":78,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[80,87,94],{"symbol":81,"name":82,"price":83,"change":84,"pct_change":85,"is_up":43,"sparkline":86,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":88,"name":89,"price":90,"change":91,"pct_change":92,"is_up":13,"sparkline":93,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":95,"name":96,"price":97,"change":98,"pct_change":99,"is_up":43,"sparkline":100,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[102,107,112,117,122,127,132,137,142,147,151],{"name":103,"etf":104,"change":105,"price":106,"is_up":43},"Technology","XLK",0.56,200.93,{"name":108,"etf":109,"change":110,"price":111,"is_up":43},"Financials","XLF",0.73,53.88,{"name":113,"etf":114,"change":115,"price":116,"is_up":43},"Healthcare","XLV",0.72,167.37,{"name":118,"etf":119,"change":120,"price":121,"is_up":43},"Consumer Cycl","XLY",0.35,110.42,{"name":123,"etf":124,"change":125,"price":126,"is_up":43},"Consumer Staples","XLP",0.63,81.04,{"name":128,"etf":129,"change":130,"price":131,"is_up":43},"Energy","XLE",0.99,63.44,{"name":133,"etf":134,"change":135,"price":136,"is_up":43},"Industrials","XLI",0.09,170.1,{"name":138,"etf":139,"change":140,"price":141,"is_up":43},"Materials","XLB",1.31,49.5,{"name":143,"etf":144,"change":145,"price":146,"is_up":13},"Real Estate","XLRE",-0.34,40.67,{"name":148,"etf":149,"change":120,"price":150,"is_up":43},"Utilities","XLU",39.97,{"name":152,"etf":153,"change":154,"price":155,"is_up":43},"Comm Services","XLC",1.17,111.61,[157,162,167,172],{"ticker":158,"name":159,"price":160,"change":161,"is_up":43},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":163,"name":164,"price":165,"change":166,"is_up":43},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":168,"name":169,"price":170,"change":171,"is_up":43},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":173,"name":174,"price":175,"change":42,"is_up":43},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":177,"articles":178},20,[179,185,191,196,201,206,210,214,219,223,228,233,238,242,247,252,257,262,266,271],{"title":180,"link":181,"pubDate":182,"description":183,"source":184},"About $20 million to $25 million a year is what Kamada expects its medicines to bring in by 2030. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxOZmN6WExWYlRoTExYb2J0N2tYZDlMQmtNMzRNaGR1RlVCaXBKVFFqMTVXRUdvZ0JxaEtQVlIwRmxyOFRsX3p4Vk5lNFlJLWtUTzB3Z0FXQlo1cmpnLUhDSlBfWlFoRjA1Umk3SWt0SVlvM1RzZ2dwSThsQ0VadGhXUlNzLWUzeXZCdFFzYjNRRG5HaUVtTkNLSk55UmFpN1RDb3dydFl4R3M4bWtVc2lfeUhZNEk4dG41d3dZeTJCNA?oc=5","Tue, 06 Oct 2026 11:00:00 GMT","About $20 million to $25 million a year is what Kamada expects its medicines to bring in by 2030. Stock Titan","Stock Titan",{"title":186,"link":187,"pubDate":188,"description":189,"source":190},"(KMDA) and the Role of Price-Sensitive Allocations - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxPWEpVWkdud2Q3V0dXY0xUM241azQ4V0NKNDBqQ0JBcTNIbUtjWUpxVGczMThpN3FLTzNCRE50QWFDMDQ1U0tMU0xDMllTNDhLQkgxWTNUdC10TFM4anZESHVTZEZfUlRkNmg1bHkxc0lTMEFzY0xCLVc3elJCN1o5aDZ4ZkV5blh6V3VsMG9xNE41M0hIcnVhclJMbHBqbGozYWlTNkFIRk1hOEJfZjJaTUxzOWxTRFRfMGVZbjhUUkVnakV0NTVzaQ?oc=5","Mon, 05 Oct 2026 22:40:01 GMT","(KMDA) and the Role of Price-Sensitive Allocations Stock Traders Daily","Stock Traders Daily",{"title":192,"link":193,"pubDate":194,"description":195,"source":184},"Dividend-linked option reset for Kamada (KMDA) VP - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxOXzB6MUdEZ0lwOGM1Zy1sQmg0LW1vdUg0M1pWa2lJWDNzT2NkcmIwSlRqa2dXRjQ1RFlxSG5zTmpoU3R0WTh4YXZ0WjVYVV80NmoxT0paUzZYOVVqNjFEVjU0MnpzUE5yUWV6UHhFa2hJZmw1cWZNR0FTWndabS1HMUJwY0RwTHBoSlBSMWlXQVNVTlZxcFBZbDNqV1BOb0NabWFEV3RMNA?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Dividend-linked option reset for Kamada (KMDA) VP Stock Titan",{"title":197,"link":198,"pubDate":199,"description":200,"source":184},"Special-dividend-adjusted options for Kamada (KMDA) VP - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxQOEh0aVUxeEQ0czduc3BVdU1WbkZmalRrdGd3MzlWMXNMZ3I2ZTNWaW13X1phV1ZVUjV5SmU2NHZoV2N4bGN1TnJySjFoNllnS1QwemFEU0dlelk2eWI5ZTFUN1djczBiSk4yeFF6MUpIc2h0bGtCeGZWdnhLdEJndWh4bzhXRnRlcC1LLWloa0ZmeTRhUmRPYUJQbXlxNkN0Nl9yX0lTUQ?oc=5","Wed, 23 Sep 2026 11:38:04 GMT","Special-dividend-adjusted options for Kamada (KMDA) VP Stock Titan",{"title":202,"link":203,"pubDate":204,"description":205,"source":184},"Kamada (KMDA) director reports 46,000 options at $6.10–$7.38 - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxQb0FqZy1saWdFblJRTk8xbXJfUGR6MVh5cWRxV0ZYUFRIMTc1S0E2T1lxLUl0SjV5T0h4bWx2QWhLSG1mVE4tS3F4SDdXV1RseXJWV0t0THREYk1mYnJYWEdDRzlNdUdSMkI1bUpRTUppOC16Qml6S2s0aEMtSTFNOVhEMXhBbFB2VEk3NXBISHVCWmF4a2lwbU9NbFBUQXlRZnpKdVRwTQ?oc=5","Wed, 23 Sep 2026 17:02:38 GMT","Kamada (KMDA) director reports 46,000 options at $6.10–$7.38 Stock Titan",{"title":207,"link":208,"pubDate":194,"description":209,"source":184},"A cash dividend lowered the exercise prices of options awarded to Kamada (KMDA) counsel Nir Livneh. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxOMHR3ZnJnNVo3eXRPQ0ZWYXdFdU9HbkRRdG5WZ2ZDc2xiUnpielZheGpZMGpmYi1RYU5oX1hVSVZQUHE4S2Z1VVhnaGFTcFoxR0diTnpOWDlwcnRFR2JrYW10S0JWa3YtdTFQMUJVQi1GTjNwb3RhalhWOXpfemhlVEhMYWd3YnFxMFNlVzAzZlBRQzlSV0hiNkloMEtBZVp0bkgyWURkaw?oc=5","A cash dividend lowered the exercise prices of options awarded to Kamada (KMDA) counsel Nir Livneh. Stock Titan",{"title":211,"link":212,"pubDate":194,"description":213,"source":184},"A special dividend changed the exercise prices on Kamada (KMDA) CFO's stock options. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxOWVNub1kwZjh1dnl2dnpsV3Z1a09uR21nRWd0blpyT1F2R0VTbEMtT1Q1enJTRXBNek0zWVhKZm5XdklHQ3ctMmg5MS1XZVZSb2ZDT2NfQ3ZwblFpcDlCRnF5THVaT3VqS0lONFpORGVOM2drWTJIcUplUXl5V0ZxcVVydS1Qc3hlY3E5dWVzMmJkalIwMTlCcXRLdnJGLW4wakpoRVBwRQ?oc=5","A special dividend changed the exercise prices on Kamada (KMDA) CFO's stock options. Stock Titan",{"title":215,"link":216,"pubDate":217,"description":218,"source":184},"A dividend changed the exercise prices on options acquired by a Kamada (KMDA) director. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxPVVowZUlBNTlUcVdyT3hZeUVNcmtBOG1SMVZjOEZKVkVKN2ctaTlCb1MyN3NIZ1pOUjZ6QWdyY3dpenBJTTZlSjZwU0JyWmQ0dFRfM3FXUjdaZ215Z2w1Z2I2T1FxZUJqbE8tYUVwY01VcUYtc0lqOExjVjBHa3hWMVFROHphTklxQUIwejdZampwNHQtR1NMR2FFZEYwVlduek04YWpKUQ?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","A dividend changed the exercise prices on options acquired by a Kamada (KMDA) director. Stock Titan",{"title":220,"link":221,"pubDate":194,"description":222,"source":184},"Kamada (NASDAQ: KMDA) grants director 46,000 options; exercise prices adjusted for dividend - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxNaWw0ajRBZktJS2o1RzUtYWRWemNTNEdYbkRFRG1GVWt2MUlxVTNMUHRqMFdyWnJkX0x3WUpqcDZRY3JRT09NZ2IxcVd1V2g4ekctTlhfWlVXX0oycUtwV2NLQk1wQy04dHYwdWYxeV9oNlVhLU0tOEl6WUNMRENBX0FuTmYtV1dzTGJfdGtPdmwxbkZ2RTlSVWRZRlIxbE5xYm9Ibk9odw?oc=5","Kamada (NASDAQ: KMDA) grants director 46,000 options; exercise prices adjusted for dividend Stock Titan",{"title":224,"link":225,"pubDate":226,"description":227,"source":184},"Kamada (KMDA) VP’s option prices were adjusted for a special dividend: $5.98 and $7.44 a share. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxPNGFTcFdHTER5NUo4eHp1Rnd4ek5TSDF4QzAzbHpvWkQwREt4UXVhbG44LW1tV2lxN2p1OFN5Ri1XeWNNR1otMHlFcHpJaWNRLTQ3MnVWUVFhanZJa05JMGVveWppdVpqMTlmSGNjbHR2TnVzd0xscDJ0LWJTdEJ2dUlGWnhoZ2VkdGY2THhsQm4yLTdEaHdwemg5MGZhaVBrZnZrY1RmSQ?oc=5","Wed, 23 Sep 2026 20:01:44 GMT","Kamada (KMDA) VP’s option prices were adjusted for a special dividend: $5.98 and $7.44 a share. Stock Titan",{"title":229,"link":230,"pubDate":231,"description":232,"source":184},"A special dividend changed the exercise prices on two stock-option awards for Kamada (KMDA)'s CEO. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxQOXN2RlZtRHlraHR3bDhFbWFtN3I1eDJPT3J2YUk5aWpVYjltMTVyTTdKXzYtRnNLX3JhVzhGY2lpaWRxWmk2SUV4WXNLeG1taGhqbEd6Q2JnSnNybkRYdnVIWl9tOVJoLUZDRTVRTjJxaWItT2JpeEdXdjRkSFRpSHFkT0VPNnI4NEZLdElqdHFrRGh5YmVwQjRvZ0kzOFZxa0tjVmhCYw?oc=5","Fri, 25 Sep 2026 10:24:10 GMT","A special dividend changed the exercise prices on two stock-option awards for Kamada (KMDA)'s CEO. Stock Titan",{"title":234,"link":235,"pubDate":236,"description":237,"source":184},"Stock options for Kamada (NASDAQ: KMDA) VP priced at $5.98 and $7.44 - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxNYkctaERMOTU5ZW1FaU9zVVRraWZVMnJCaGUyVTRDaG5EOUpyZ3U3NGRUZEM2NUFjUXBSWmJjWFJvVElyeUUwbHJJcEs1aGZMNURxZURZQ0UtbTMxZ0x1TzJwZ1NMb1ZQcnhMUTZaTG56YmhYTmgtSlJ0SzNPQlZpamFTUVBmeXVnbGdrWXpjQ2VIdnN1TlRnRU5oaVc5N1F0MTFpcGRQdw?oc=5","Wed, 23 Sep 2026 16:54:51 GMT","Stock options for Kamada (NASDAQ: KMDA) VP priced at $5.98 and $7.44 Stock Titan",{"title":239,"link":240,"pubDate":217,"description":241,"source":184},"Kamada (KMDA) HR VP receives two option awards that vest in four annual installments. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxNZDhVS2NtbXZYQ05jQjRhczVCR1NKR2FEc3NMdnVsLTVmcE9VRHhFZG5QX3lDRWFOYTdjdkdDdzVnOTRyY1BnSTU4S2kyeFRrT0tnTmNHQURaTjJBdUdRUF9kNENMUlo0a3p3WGFBSFdFNk52QnZMM1RUN2pKUk1BdmxENEd3M0xyMTZlbVMtelgxWk42VEZxaWpKSUt2THFHNHFkbWxBYw?oc=5","Kamada (KMDA) HR VP receives two option awards that vest in four annual installments. Stock Titan",{"title":243,"link":244,"pubDate":245,"description":246,"source":184},"A special cash dividend led Kamada (KMDA) to adjust a VP’s stock option prices to $5.98 and $7.44. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxPTldBTGNUTWJQNUNleVFRY1YzUTF0WnJrWUNpeENMVXNGdzhfajB3OUhVX1h6UnlkN1lHOW9NbUVxZUR0bTRJemU5ejZQMG5PVDFjZnJHUmQ2T3Jlci1oUGlBaE0wd3h4eWNLN2lrMTBhLXFCR1E4cE5Vc01uQU9fWUY4bzlmeUhtZUJLQ2h3SVI5NklsNWw2MjRLYXZ0UDhEMm0ybi1TQQ?oc=5","Thu, 24 Sep 2026 11:34:23 GMT","A special cash dividend led Kamada (KMDA) to adjust a VP’s stock option prices to $5.98 and $7.44. Stock Titan",{"title":248,"link":249,"pubDate":250,"description":251,"source":184},"Kamada (KMDA) director Ishay Davidi's previously reported options carry three adjusted exercise prices. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxOdl90X0REX05YMHhBSUtOMGlNVVE5VXVZRzQtQWxKdS1wZjd1UVhpT3VEaV9fUnFiaXZPWFNWeUY0UTB2alZmOVpoSmN6emNlQ3JteWlqWGxORFhHTHBOMkZGOGZ6emdSR01jTmhmLVhCd0prVVJCYWVrNlhMMTVrcm5lM3BqTnlnS1BPX2xCU0w3ZGREYTQ4Y1BESHp4dGZYVURlTkZ2VQ?oc=5","Tue, 29 Sep 2026 13:13:29 GMT","Kamada (KMDA) director Ishay Davidi's previously reported options carry three adjusted exercise prices. Stock Titan",{"title":253,"link":254,"pubDate":255,"description":256,"source":184},"A special cash dividend adjusted the exercise prices on Kamada (KMDA) director Uri Botzer’s options. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxOY1hVX0IzTVRwalJqVDNSMF80TDYycnM4QUNLZXlPUXJJOUlfcUdQNWliOGJPUGJ3UkNuSkpsVl9sWjlONS1SaFVQY25vaHZvS042TEQ0WE56eHMwREktSkVKbkVITTNTQUhQdjRTMXJsaS04cG4ydHV6SWFQdU05bG5FdF92ZFZRZzFEa3k3Rk5QMGV2S0N1UXFJckltTHJzdnB3YXR1QQ?oc=5","Tue, 29 Sep 2026 13:08:27 GMT","A special cash dividend adjusted the exercise prices on Kamada (KMDA) director Uri Botzer’s options. Stock Titan",{"title":258,"link":259,"pubDate":260,"description":261,"source":184},"Kamada (NASDAQ: KMDA) grants director 37,500 share options - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxQa2RzZFJRUFd6UmREOWwwTlVyUDk0VG5xRVBaRzBkbUZTSnFPZkVCYm9XeXp6TFA3YjBTMEtTZVgwLUpvekctV2phYkhFaFFSY2EzeU83TnNTazJmamhPalc4MkdRTHIzck10R0ZPVm85aWkxWkRsb2xIZUpNZXRZcmIxaWdHY2lCYllNMXBnSGdUWjg1Y19xUVQ1aFFrOUpkb2FjMHliSQ?oc=5","Wed, 23 Sep 2026 11:14:41 GMT","Kamada (NASDAQ: KMDA) grants director 37,500 share options Stock Titan",{"title":263,"link":264,"pubDate":217,"description":265,"source":184},"Three option awards for a Kamada (KMDA) director carry prices from $5.99 to $7.41 per share. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxPQUdGQWV3Vy0tbk41WDA4ODBvZE40bU0zVFhVc21DMEkyWndNdzE3eUs2dnFWTlVtdWdYblptLTZpenI4WmhfWEZYcmQ0SGVXcS14S0lMdHRnYmxKUHh6ODMzRkxxdVJBQkRoLVV3UDM4TnlKZ0lUWlhCb2dUOUxTbndzWXc4QkJYNGZUNm1hWEk2eHBkS2lsaUFnQ0xnR2diOGxra2FHZw?oc=5","Three option awards for a Kamada (KMDA) director carry prices from $5.99 to $7.41 per share. Stock Titan",{"title":267,"link":268,"pubDate":269,"description":270,"source":184},"No pre-approval inventory costs were booked as assets in 2024–25, Kamada (KMDA) says. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxPZi1fa2VvdjJnZ211cXJsajNQU0RiQ2xteEMtd0p1Q3l6NGJ1SEhpOWdHcVMtc0J0UDJlSDBVTTR2cGF6STZZdG42MldlbVFnUXNvZlJkQ19BdG9vanE4UXR1QVVsSUFGN0w4bDVOYzBCdHJxOTViN2R1b1pyQUdvdmlaRF90dy1VNnVQVnhDUV9KbmRiMEtSeXIwQmtyczdDMmU3RXI1YnVhZw?oc=5","Mon, 05 Oct 2026 20:00:33 GMT","No pre-approval inventory costs were booked as assets in 2024–25, Kamada (KMDA) says. Stock Titan",{"title":272,"link":273,"pubDate":274,"description":275,"source":184},"Two drug launches in Israel expand Kamada (KMDA)'s portfolio as it projects sales through 2030. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxOcFB6N3BTS3Q2bW14X3UzNElvWk9hSVpreWN3VFpjNW5ySUlzV0pzUm1PU05TT2lCdWQtNUJZS2tiYUNyYTFvY2hwT1hlTGx1clBCaWJzdUNoNG13MVo3YXIzUy13dUZRRC1UbHV1ZndSZDRRMEFYWlVCTVNmejVISFpYSGE2eG9IaUZPaHlzeWpEamJ2Sjh2QjZTU3MwUzFUck1Pc0VtRUFRdw?oc=5","Tue, 06 Oct 2026 11:00:57 GMT","Two drug launches in Israel expand Kamada (KMDA)'s portfolio as it projects sales through 2030. Stock Titan"]